Kristensen JS - Search Results

1

Reasons for treating secondary AML as de novo AML.

Ostgård LS, Kjeldsen E, Holm MS, Brown Pde N, Pedersen BB, Bendix K, Johansen P, Kristensen JS, Nørgaard JM. Ostgård LS, et al. Among authors: kristensen js. Eur J Haematol. 2010 Sep;85(3):217-26. doi: 10.1111/j.1600-0609.2010.01464.x. Epub 2010 Apr 29. Eur J Haematol. 2010. PMID: 20456491

2

Addressing the room for improvement in management of acute promyelocytic leukemia.

Nørgaard JM, Friis LS, Kristensen JS, Severinsen MT, Mølle I, Marcher CW, Møller P, Schoellkopf C, Nielsen OJ, Preiss BS, Andersen MK, Kjeldsen E, Medeiros BC, Østgård LSG; Danish Acute Leukemia Group. Nørgaard JM, et al. Among authors: kristensen js. Eur J Haematol. 2019 Jun;102(6):479-485. doi: 10.1111/ejh.13229. Epub 2019 Apr 7. Eur J Haematol. 2019. PMID: 30887583

3

Leukaemia cell drug resistance and prognostic factors in AML.

Nørgaard JM, Olesen G, Kristensen JS, Pedersen B, Hokland P. Nørgaard JM, et al. Among authors: kristensen js. Eur J Haematol. 1999 Oct;63(4):219-24. doi: 10.1111/j.1600-0609.1999.tb01881.x. Eur J Haematol. 1999. PMID: 10530409

4

FAB M4 and high CD14 surface expression is associated with high cellular resistance to Ara-C and daunorubicin: implications for clinical outcome in acute myeloid leukaemia.

Nørgaard JM, Olesen LH, Olesen G, Meyer K, Kristensen JS, Bendix K, Pedersen B, Kjeldsen E, Hokland P. Nørgaard JM, et al. Among authors: kristensen js. Eur J Haematol. 2001 Oct;67(4):221-9. doi: 10.1034/j.1600-0609.2001.00553.x. Eur J Haematol. 2001. PMID: 11860442

5

High serum concentration of YKL-40 is associated with short survival in patients with acute myeloid leukemia.

Bergmann OJ, Johansen JS, Klausen TW, Mylin AK, Kristensen JS, Kjeldsen E, Johnsen HE. Bergmann OJ, et al. Among authors: kristensen js. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8644-52. doi: 10.1158/1078-0432.CCR-05-1317. Clin Cancer Res. 2005. PMID: 16361549

6

Hybrid acute leukemia: therapeutical implications of immunological phenotyping.

Kristensen JS, Jensen AW, Jensen IM, Pedersen B, Ellegaard J, Hokland P. Kristensen JS, et al. Anal Cell Pathol. 1992 Mar;4(2):69-79. Anal Cell Pathol. 1992. PMID: 1550796

7

Stromal-mediated down-regulation of CD13 in bone marrow cells originating from acute myeloid leukemia patients.

Dybkaer K, Olesen G, Pedersen FS, Kristensen JS. Dybkaer K, et al. Among authors: kristensen js. Eur J Haematol. 2001 Mar;66(3):168-77. doi: 10.1034/j.1600-0609.2001.00310.x. Eur J Haematol. 2001. PMID: 11350485

8

Single site polymorphisms and alternative splicing of the human CD13 gene--different splicing frequencies among patients with acute myeloid leukaemia and healthy individuals.

Dybkaer K, Kristensen JS, Pedersen FS. Dybkaer K, et al. Among authors: kristensen js. Br J Haematol. 2001 Mar;112(3):691-6. doi: 10.1046/j.1365-2141.2001.02613.x. Br J Haematol. 2001. PMID: 11260074 Free article.

9

Monoclonal antibody ratios in malignant myeloid diseases: diagnostic and prognostic use in myelodysplastic syndromes.

Kristensen JS, Hokland P. Kristensen JS, et al. Br J Haematol. 1990 Mar;74(3):270-6. doi: 10.1111/j.1365-2141.1990.tb02582.x. Br J Haematol. 1990. PMID: 2334636

10

Evolution of Ig- and T-cell receptor gene configuration in a Ph1+ hybrid leukemia patient.

Jensen AW, Hokland P, Kristensen JS, Justesen J, Hokland M. Jensen AW, et al. Among authors: kristensen js. Eur J Haematol. 1992 Feb;48(2):105-9. doi: 10.1111/j.1600-0609.1992.tb00574.x. Eur J Haematol. 1992. PMID: 1312481

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page